基本信息
views: 78
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Wim van Harten spent 7 years after his graduation as M.D. in tropical medicine. On returning from Cameroon, Africa he decided to focus on public health and health administration. He obtained a degree in community medicine while working as a chief medical advisor of a major health insurance company (1986-1992). As a director of patient care/General director he worked in rehabilitation hospital “Het Roessingh” (1992-2001) in Enschede, he finished his PhD on quality management (1997).
From 2001-2015 he was a member of the executive board of the National Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL) in Amsterdam, The Netherlands, responsible for Organisation & Management.
From 2015 on wards he is CEO of Rijnstate Hospital a large teaching hospital in Arnhem, The Netherlands.
In 2005 he started, also at the NKI-AVL, as project leader at the Division of Psychosocial Research and Epidemiology and still active in this role.
Since 2001 he is part-time professor on the chair “Quality Management of Health Care Technology” at the department of Health Technology and Services Research of the School of Management and Governance at the University of Twente, the Netherlands.
From 2006 on wards he is a board member and since 2011 until June 2014 president of the OECI (Organisation of European Cancer Institutes). After leaving the board in 2017 as "emeritus President” of the OECI he is still active as Accreditation Chair and chairing the Working Group on health Economics.
From 2008 – June 2014 onward he was a board member of the Netherlands Hospital Association.
Research Interests
Papers共 330 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Breast Cancer Research and Treatmentno. 1 (2024): 1-12
European Journal of Cancer (2024): 113626
Renske M. T. ten Ham,Maartje W. Rohaan,Inge Jedema,Rob Kessels, Wim Stegeman, Walter Scheepmaker,Bastiaan Nuijen,Cynthia Nijenhuis,Melanie Lindenberg,Troels Holz Borch,Tine Monberg,Marco Donia,
JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 3 (2024)
Michael Schlander,Wim van Harten,Valesca P. Retel, Phu Duy Pham,Julie M. Vancoppenolle,Jasper Ubels, Olaya Seoane Lopez, Camila Quirland, Felipe Maza, Eline Aas, Bernd Crusius, Agustin Escobedo,
LANCET ONCOLOGYno. 4 (2024): e152-e163
Mayo Clinic Proceedings: Digital Health (2024)
Nick J. Koning, Joost L. C. Lokin,Lian Roovers,Jan Willem Kallewaard,Wim H. van Harten,Cor J. Kalkman,Benedikt Preckel
JOURNAL OF CLINICAL MEDICINEno. 2 (2024): 534
L F van Schaik,E G Engelhardt,E A Wilthagen,N Steeghs, A Fernández Coves,M A Joore,W H van Harten,V P Retèl
Critical reviews in oncology/hematology (2024): 104441-104441
SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTSno. 2 (2024): e14575-e14575
eHealth Research Theory and Developmentpp.53-70, (2024)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn